Endo International PLC

Endo International plc is a specialty pharmaceutical company that manufactures and sells generic and branded pharmaceuticals in the United States and internationally. It operates in four segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceuticals. The company offers branded products such as XIAFLEX, SUPPRELIN LA, AVEED, NASCOBAL, QWO, PERCOCET, TESTOPEL, and EDEX, as well as ADRENALIN, VASOSTRICT, and APLISOL, and generic sterile injectables. It also provides solid oral extended-release and immediate-release products, liquids, semi-solids, patches, powders, ophthalmic products, and sprays, and sells to specialty physicians, wholesale distributors, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Founded in 1920 and headquartered in Dublin, Ireland, the company filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York on August 16, 2022.